secwatch.observer — SEC 8-K summary
======================================

Issuer:     VOLITIONRX LTD (VNRX)
CIK:        0000093314
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001477932-26-002619
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

VolitionRx completes 1-for-20 reverse stock split effective April 28, 2026
--------------------------------------------------------------------------

- Stockholders approved reverse split at special meeting March 31, 2026; Board set ratio at 1:20.
- Certificate of Amendment filed with Delaware on April 27, 2026, effective 12:01 a.m. ET April 28, 2026.
- Reverse split applies to all outstanding common shares; fractional shares treated per amendment.
- Common stock continues trading on NYSE American under ticker VNRX.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/93314/000147793226002619/0001477932-26-002619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/93314/000147793226002619/vnrx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-002619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer